Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Expression of Integrin-linked Kinase is not a Useful Prognostic Marker in Resected Hepatocellular Cancer

PONGPHOB INTARAPRASONG, KIRAN ASSI, DAVID A. OWEN, DAVID G. HUNTSMAN, STEPHEN W. CHUNG, CHARLES H. SCUDAMORE, ERIC M. YOSHIDA and BALJINDER SALH
Anticancer Research November 2007, 27 (6C) 4371-4376;
PONGPHOB INTARAPRASONG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KIRAN ASSI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID A. OWEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID G. HUNTSMAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHEN W. CHUNG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARLES H. SCUDAMORE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERIC M. YOSHIDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BALJINDER SALH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bsalh@interchange.ubc.ca
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 27 no. 6C 4371-4376
PubMed 
18214046

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received April 25, 2007
  • Revision received August 28, 2007
  • Accepted October 4, 2007
  • Published online November 1, 2007.

Copyright & Usage 
Copyright© 2007 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. PONGPHOB INTARAPRASONG1,
  2. KIRAN ASSI1,
  3. DAVID A. OWEN2,
  4. DAVID G. HUNTSMAN3,
  5. STEPHEN W. CHUNG4,
  6. CHARLES H. SCUDAMORE4,
  7. ERIC M. YOSHIDA1 and
  8. BALJINDER SALH1
  1. 1Department of Medicine, University of British Columbia, Vancouver BC, Canada
  2. 2Department of Pathology, University of British Columbia, Vancouver BC, Canada
  3. 3Department of Genetic Pathology Evaluation Center, University of British Columbia, Vancouver BC, Canada
  4. 4Department of Hepatobiliary Surgery, University of British Columbia, Vancouver BC, Canada
  1. Correspondence to: Dr. B. Salh, Division of Gastroenterology, Department of Medicine, University of British Columbia, 5153 - 2775 Laurel Street, Vancouver BC V5Z 1M9, Canada. Tel: +1 6048755287, Fax: +1 6048755447, e-mail: bsalh{at}interchange.ubc.ca

Statistics from Altmetric.com

Cited By...

  • 9 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 27 (6C)
Anticancer Research
Vol. 27, Issue 6C
November-December 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expression of Integrin-linked Kinase is not a Useful Prognostic Marker in Resected Hepatocellular Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 14 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Expression of Integrin-linked Kinase is not a Useful Prognostic Marker in Resected Hepatocellular Cancer
PONGPHOB INTARAPRASONG, KIRAN ASSI, DAVID A. OWEN, DAVID G. HUNTSMAN, STEPHEN W. CHUNG, CHARLES H. SCUDAMORE, ERIC M. YOSHIDA, BALJINDER SALH
Anticancer Research Nov 2007, 27 (6C) 4371-4376;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Expression of Integrin-linked Kinase is not a Useful Prognostic Marker in Resected Hepatocellular Cancer
PONGPHOB INTARAPRASONG, KIRAN ASSI, DAVID A. OWEN, DAVID G. HUNTSMAN, STEPHEN W. CHUNG, CHARLES H. SCUDAMORE, ERIC M. YOSHIDA, BALJINDER SALH
Anticancer Research Nov 2007, 27 (6C) 4371-4376;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial
  • Assessment of Breakthrough Cancer Pain Among Female Patients With Cancer: Knowledge, Management and Characterization in the IOPS-MS Study
  • Low-dose Apalutamide in Non-metastatic Castration-resistant Prostate Cancer: A Case Series
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire